State of Nevada: Drug Transparency Report 2022

This report is submitted pursuant to the requirements of Nevada Revised Statutes (NRS) 439B.650.

On or before June 1 of each year, the Department shall analyze the information submitted pursuant to NRS 439B.635, 439B.640 and 439B.645 and compile a report on the price of the prescription drugs that appear on the most current lists compiled by the Department pursuant to NRS 439B.630, the reasons for any increases in those prices and the effect of those prices on overall spending on prescription drugs in this State. The report may include, without limitation, opportunities for persons and entities in this State to lower the cost of drugs while maintaining access to such drugs.

Type: Report
Topic(s): Substance Use
Year: 2022
Lead Agency:
Nevada Department of Health and Human Services
Occurs:
Annually
General Contact
Name: Richard Whitley
Phone: 7756844257
Email: drugtransparency@dhhs.nv.gov
Skip to content